Lead researcher and CEO of POP Biotechnologies, Dr. Jonathan Lovell is based at the University at Buffalo. Dr. Lovell said ...

The Sabin Vaccine Institute has launched a multi-site Phase 2 clinical trial in the U.S. for its Marburg vaccine candidate, ...

The Sabin Vaccine Institute has begun a Phase II trial in the US to evaluate its Marburg vaccine, with the first doses being ...

Africa bears a disproportionate infectious disease burden, with HIV, tuberculosis, and malaria posing ongoing threats ...

Vaccination campaigns have nearly eradicated some of the most deadly and transmissible diseases. In a rising tide of vaccine ...

A global emergency stockpile of Ebola vaccine is being deployed to curb the epidemic, although experts are confident that synergies in public health practises will ensure a rapid response to both.

The Sabin Vaccine Institute has launched a multi-site Phase 2 clinical trial in the U.S. for its Marburg vaccine candidate, administering doses to the ...

President Donald Trump's administration plans to end U.S. funding for Gavi, an organization that helps buy vaccines for children in poor countries, and will scale back efforts to fight malaria, ...

EQS-News: GeoVax, Inc. / Key word (s): Financial GeoVax Receives USPTO Notice of Allowance for Marburg Hemorrhagic Fever Vaccine Patent 09.04.2025 / 15:07 CET/CEST The issuer is solely responsible ...

Sweeping job cuts and reorganizations taking place at the US Department of Health and Human Services under Secretary Robert F. Kennedy Jr. leave the United States “weaker as a nation,” Dr. Peter Marks ...

Craig Spencer, a doctor and Ebola survivor at Brown University, said the loss of US support to Gavi means "kids will die". He also warned that Gavi maintains the global stockpile of vaccines for ...